American National Bank acquired 4,590 shares as Abbvie Inc (ABBV)'s stock rose 6.17%. The stock increased 1.42% or $0.17 during the last trading session, reaching $12.18. The company had a trading volume of 8,898,671 shares, compared to its average volume of 6,960,000. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since February 10, 2017 and is uptrending. It has underperformed by 25.91% the S&P500.
Jay Petschek increased its stake in Kraton Corporation (KRA) by 18.12% based on its latest 2017Q3 regulatory filing with the SEC. Insiders sold 373,191 shares of company stock worth $26,598,305 over the last 90 days. The hedge fund run by Jay Petschek held 195,577 shares of the basic industries company at the end of 2017Q3, valued at $7.91M, up from 165,577 at the end of the previous reported quarter. Gillespie Robinson & Grimm Inc who had been investing in Lowe'S Companies for a number of months, seems to be less bullish one the $80.63B market cap company. Ffcm LLC now owns 1,539 shares of the company's stock worth $111,000 after acquiring an additional 963 shares during the period. During the same period last year, the firm earned $1.20 EPS. sell-side analysts predict that AbbVie will post 7.46 earnings per share for the current fiscal year. (NYSE:ABBV) on Monday, October 30. It has outperformed by 1.89% the S&P500.
Comml Bank Of Montreal Can invested in 5.06 million shares or 0.41% of the stock. ValuEngine raised AbbVie from a "hold" rating to a "buy" rating in a research note on Friday, February 2nd. (NYSE:ABBV). Needelman Asset Management accumulated 10,057 shares. (NYSE:ABBV) was sold by SALEKI-GERHARDT AZITA. On Monday, December 18 RICHMOND TIMOTHY J. sold $8.57 million worth of AbbVie Inc. It also increased its holding in Bank New York Mellon Corp (NYSE:BK) by 39,750 shares in the quarter, for a total of 93,322 shares, and has risen its stake in Boardwalk Pipeline Partners (NYSE:BWP).
News stories about AbbVie (NYSE:ABBV) have trended somewhat positive this week, Accern Sentiment Analysis reports. Therefore 50% are positive. Hudock Capital Group LLC grew its holdings in shares of AbbVie by 109.5% in the 2nd quarter. Morgan Stanley maintained JPMorgan Chase & Co. The firm has "Buy" rating given on Tuesday, December 5 by Leerink Swann. Also, insider Laura J. Schumacher sold 145,510 shares of AbbVie stock in a transaction dated Friday, December 15th. 6,950 shares valued at $329,360 were sold by Simmons James Leo on Friday, October 27. BMO Capital Markets maintained it with "Hold" rating and $66.0 target in Wednesday, October 11 report. (NYSE:ABBV) earned " rating by Citigroup on Monday, September 28. The rating was maintained by Jefferies with "Buy" on Thursday, January 4. AbbVie earned a media sentiment score of 0.21 on Accern's scale. Its down 0.15, from 1 in 2017Q2. It worsened, as 55 investors sold ABBV shares while 640 reduced holdings. 23 funds opened positions while 52 raised stakes. Brave Asset Management invested 0.83% of its portfolio in JPMorgan Chase & Co. (NYSE:ABBV). Haverford owns 90,901 shares or 0.17% of their USA portfolio. Finally, Tradewinds Capital Management LLC boosted its stake in AbbVie by 87.2% in the first quarter. Zurcher Kantonalbank (Zurich Cantonalbank) accumulated 539,799 shares or 0.45% of the stock. Barrett Asset Management Limited Liability invested 0.01% in CSX Corporation (NASDAQ:CSX). Advsr Ltd Limited Liability Co holds 0.03% in AbbVie Inc. Schwab Charles Mngmt holds 0.01% or 233,181 shares in its portfolio. Parsons Mngmt Ri accumulated 319,504 shares. AbbVie has a 1-year low of $60.15 and a 1-year high of $125.86. TheStreet upgraded the shares of ABBV in report on Tuesday, August 11 to "Buy" rating.
Healthcor Management Lp, which manages about $3.20B and $2.98 billion US Long portfolio, decreased its stake in Danaher Corp Del (NYSE:DHR) by 150,380 shares to 1.25 million shares, valued at $107.39M in 2017Q3, according to the filing.
ABBV has been the subject of a number of research reports. Following the completion of the sale, the chairman now owns 342,353 shares in the company, valued at $24,313,910.06. Amica Retiree Medical reported 917 shares.
Among 4 analysts covering Kraton Performance Polymers (NYSE:KRA), 2 have Buy rating, 1 Sell and 1 Hold. Lowe's Companies Inc. had 86 analyst reports since August 19, 2015 according to SRatingsIntel. The firm earned "Buy" rating on Tuesday, April 12 by Jefferies. Stifel Nicolaus maintained it with "Buy" rating and $8700 target in Thursday, July 20 report. UBS has "Buy" rating and $78 target. The firm has "Hold" rating given on Sunday, July 30 by BMO Capital Markets. It is involved in the acquisition of accounts that are primarily the unpaid obligations of individuals owed to credit grantors, which include banks and other types of consumer, retail, and auto finance companies. The rating was maintained by Keefe Bruyette & Woods on Wednesday, October 14 with "Outperform". AbbVie has an average rating of "Buy" and a consensus target price of $117.26. The rating was maintained by BMO Capital Markets on Wednesday, August 23 with "Hold". Vanguard Group Inc. now owns 115,920,673 shares of the company's stock worth $8,405,409,000 after buying an additional 3,706,941 shares during the period. The shares were sold at an average price of $96.71, for a total value of $14,072,272.10. On Tuesday, October 31 the insider Lindekugel Jon T sold $92,023. Little Frank R Jr. sold $560,200 worth of stock or 2,719 shares. Its down 0.14, from 0.91 in 2017Q2. Pacad Invest invested in 0.21% or 10,493 shares. The company reported $1.48 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.44 by $0.04. Sei Invests has 198,874 shares. Ballentine Ptnrs Ltd Liability holds 8,114 shares or 0.04% of its portfolio. (NYSE:ABBV). Argent Trust invested in 55,786 shares or 1.36% of the stock. Bradley Foster & Sargent Ct owns 162,005 shares for 0.55% of their portfolio. Colonial Tru Advisors, a South Carolina-based fund reported 10,446 shares. Woodmont Invest Counsel holds 0.32% or 21,327 shares. 1,100 were reported by Invest. The Colorado-based Pub Employees Retirement Association Of Colorado has invested 0.02% in EQT Corporation (NYSE:EQT). The company has market cap of $51.97 million.